Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients

dc.authorid0000-0002-5420-7563
dc.authorid0000-0002-0359-1710
dc.authorid0000-0002-6827-0053
dc.authorid0000-0003-1405-618X
dc.authorwosidHGC-5530-2022
dc.contributor.authorEker Büyükşireci, Dilek
dc.contributor.authorÇağlıyan Türk, Ayla
dc.contributor.authorErden, Ender
dc.contributor.authorErden, Ebru
dc.date.accessioned2023-01-27T12:08:57Z
dc.date.available2023-01-27T12:08:57Z
dc.date.issued2022en_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractAbstract Background Psychological stressors may cause mental disorders such as anxiety, depression, and post-traumatic stress disorders and fbromyalgia (FM) patients could be afected by these stressors. Aim To evaluate pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in patients with FM. Methods According to the 2016 American College of Rheumatology (ACR) criteria, ffty-seven patients with FM alone and 77 patients with FM and recovering from COVID-19 infection were recruited to the study (group 1: patients with FM alone and group 2: patients with FM and recovering from COVID-19). Demographic and clinical characteristics were recorded. The pain level was determined by the Numerical Rating Scale (NRS), the pain regions by the Widespread Pain Index (WPI) of the 2016 ACR criteria, the severity of the symptoms by the Symptom Severity Scale (SSS) of the 2016 ACR criteria, the disease activity by the Fibromyalgia Impact Questionnaire (FIQ), the anxiety and depression levels by the Hospital Anxiety and Depression Scale (HADS), and the neuropathic pain level by Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale (LANSS). Results Age, height, weight, Body Mass Index (BMI), and the duration of FM diagnosis were similar in both groups (p>0.05). NRS, FIQ, HADS depression scale, and SSS and LANSS scores were similar between group 1 and group 2 (p>0.05). HADS anxiety score and WPI were signifcantly increased in group 2 (p=0.026 and p=0.024 respectively). Conclusions Anxiety and widespread pain levels were higher in patients with FM and recovering from COVID-19 infection.
dc.identifier.citationBüyükşireci, D. E., Türk, A. Ç., Erden, E., & Erden, E. (2022). Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients. Irish Journal of Medical Science (1971-), 1-7.
dc.identifier.endpage7en_US
dc.identifier.issn0021-1265
dc.identifier.issn1863-4362
dc.identifier.pmid35794340
dc.identifier.scopusqualityQ1
dc.identifier.startpage1en_US
dc.identifier.urihttp://dx.doi.org/10.1007/s11845-022-03081-z
dc.identifier.urihttps://hdl.handle.net/11491/8438
dc.identifier.wosWOS:000824798000001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherSPRINGER LONDON LTD
dc.relation.ispartofIRISH JOURNAL OF MEDICAL SCIENCE
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectDisease activityen_US
dc.subjectFibromyalgiaen_US
dc.subjectNeuropathic painen_US
dc.subjectPainen_US
dc.subjectPost-COVID-19 infectionen_US
dc.titleEvaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patients
dc.typeArticle

Dosyalar